Home › NDC Lookup › RxCUI directory › RxCUI 1654169

2 ML adenosine 3 MG/ML Injection — RxCUI 1654169

RxNorm drug concept · Semantic clinical drug
RxCUI 1654169 Semantic clinical drug · SCD ● Current RxNorm concept 15 FDA products 19 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1654169
Official name2 ML adenosine 3 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asadenosine 6 MG per 2 ML Injection; adenosine 6 MG in 2 ML Injection
FDA products mapped15
Package NDCs mapped19
Reported Medicaid activity (SDUD)1,015 prescriptions · 10 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How 2 ML adenosine 3 MG/ML Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 2 ML adenosine 3 MG/ML Injection RxCUI 1654169

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Adenosine 296
  2. Dose forms 4

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Adenosine Injection 1654034
    • Adenosine Injectable Product 1153467
    • Injection 1649574
    • Injectable Product 1151126
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Adenosine 3 MG/ML 315283

Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Adenosine 3 MG/ML SCDC · 315283
  • Adenosine Injection SCDF · 1654034
  • Adenosine Injectable Product SCDG · 1153467

📦 FDA Products & Package NDCs

15 products · 19 package NDCs
19 package NDCs map to RxCUI 1654169 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00404-9993-02 1 VIAL, SINGLE-USE in 1 BAG (0404-9993-02) / 2 mL in 1 VIAL... ADENOSINE Henry Schein, Inc. 2023-06-28
25021-0318-02 10 VIAL in 1 CARTON (25021-318-02) / 2 mL in 1 VIAL Adenosine Sagent Pharmaceuticals 2023-03-15
25021-0318-04 10 VIAL in 1 CARTON (25021-318-04) / 4 mL in 1 VIAL Adenosine Sagent Pharmaceuticals 2023-03-15
51662-1631-01 2 mL in 1 VIAL, SINGLE-DOSE (51662-1631-1) ADENOSINE HF Acquisition Co LLC, DBA HealthFirst 2023-04-28
51662-1632-01 2 mL in 1 VIAL, SINGLE-USE (51662-1632-1) ADENOSINE HF Acquisition Co LLC, DBA HealthFirst 2023-06-23
63323-0651-02 10 VIAL, SINGLE-USE in 1 TRAY (63323-651-02) / 2 mL in 1 VI... Adenosine Fresenius Kabi USA, LLC 2005-11-23
63323-0651-04 10 VIAL, SINGLE-USE in 1 TRAY (63323-651-04) / 4 mL in 1 VI... Adenosine Fresenius Kabi USA, LLC 2005-11-23
63323-0651-20 1 VIAL, SINGLE-DOSE in 1 CARTON (63323-651-20) / 20 mL in 1... Adenosine Fresenius Kabi USA, LLC 2017-11-27
63323-0651-30 1 VIAL, SINGLE-DOSE in 1 CARTON (63323-651-30) / 30 mL in 1... Adenosine Fresenius Kabi USA, LLC 2017-11-27
67457-0854-04 10 VIAL, SINGLE-DOSE in 1 CARTON (67457-854-04) / 4 mL in 1... adenosine Mylan Institutional LLC 2018-05-08
67457-0855-02 10 VIAL, SINGLE-DOSE in 1 CARTON (67457-855-02) / 2 mL in 1... adenosine Mylan Institutional LLC 2018-05-08
68083-0156-10 10 VIAL in 1 CARTON (68083-156-10) / 2 mL in 1 VIAL Adenosine Gland Pharma Limited 2017-01-13
68083-0157-10 10 VIAL in 1 CARTON (68083-157-10) / 4 mL in 1 VIAL Adenosine Gland Pharma Limited 2017-01-13
70518-4207-00 10 VIAL in 1 CARTON (70518-4207-0) / 2 mL in 1 VIAL (70518-... Adenosine REMEDYREPACK INC. 2024-10-10
70518-4207-02 10 VIAL in 1 CARTON (70518-4207-2) / 4 mL in 1 VIAL (70518-... Adenosine REMEDYREPACK INC. 2024-12-06
71872-7209-01 1 VIAL, SINGLE-DOSE in 1 BAG (71872-7209-1) / 2 mL in 1 VIA... adenosine Medical Purchasing Solutions, LLC 2020-03-30
71872-7335-01 1 VIAL in 1 BAG (71872-7335-1) / 2 mL in 1 VIAL Adenosine Medical Purchasing Solutions, LLC 2024-11-25
72078-0033-02 10 VIAL, SINGLE-DOSE in 1 CARTON (72078-033-02) / 2 mL in 1... adenosine Mylan Institutional LLC 2022-04-06
84549-0318-02 2 mL in 1 VIAL (84549-318-02) Adenosine ProPharma Distribution 2025-08-27
Observed labelers: Fresenius Kabi USA, LLC (4) · Mylan Institutional LLC (3) · Gland Pharma Limited (2) · HF Acquisition Co LLC, DBA HealthFirst (2) · Medical Purchasing Solutions, LLC (2) · REMEDYREPACK INC. (2) · +3 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J0153 Adenosine inj 1mg 11 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.